Tianjin Chase Sun Pharmaceutical Co Ltd (300026) — Free Cash Flow Generation Index
Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Free Cash Flow Generation Index of 0.86x as of September 2025. Free cash flow of CN¥131.73 Million represents 1% of operating cash flow (CN¥153.30 Million). Read Tianjin Chase Sun Pharmaceutical Co Ltd (300026) total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Tianjin Chase Sun Pharmaceutical Co Ltd Free Cash Flow Generation Index (2006–2024)
Historical FCF Generation Index trend for Tianjin Chase Sun Pharmaceutical Co Ltd across 19 annual periods. Explore 300026 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)
Year-by-year Free Cash Flow Generation Index for Tianjin Chase Sun Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Tianjin Chase Sun Pharmaceutical Co Ltd market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.77x | CN¥659.12 Million | CN¥852.24 Million | CN¥193.12 Million | ▲ +0.0% |
| 2023 | 0.77x | CN¥1.18 Billion | CN¥1.53 Billion | CN¥347.12 Million | ▲ +2411.9% |
| 2022 | -0.03x | CN¥-24.93 Million | CN¥745.35 Million | CN¥770.27 Million | ▲ +95.4% |
| 2021 | -0.73x | CN¥-285.85 Million | CN¥391.60 Million | CN¥677.45 Million | ▲ +60.9% |
| 2020 | -1.87x | CN¥-367.12 Million | CN¥196.66 Million | CN¥563.78 Million | ▼ -7.6% |
| 2019 | -1.73x | CN¥-374.91 Million | CN¥216.10 Million | CN¥591.01 Million | ▼ -821.8% |
| 2018 | 0.24x | CN¥93.30 Million | CN¥388.19 Million | CN¥294.89 Million | ▼ -50.3% |
| 2017 | 0.48x | CN¥359.04 Million | CN¥742.38 Million | CN¥383.34 Million | ▲ +565.7% |
| 2016 | 0.07x | CN¥32.55 Million | CN¥448.08 Million | CN¥415.52 Million | ▲ +108.6% |
| 2015 | -0.85x | CN¥-102.36 Million | CN¥121.00 Million | CN¥223.35 Million | ▼ -346.1% |
| 2014 | -0.19x | CN¥-28.43 Million | CN¥149.94 Million | CN¥178.37 Million | ▼ -174.8% |
| 2013 | 0.25x | CN¥36.40 Million | CN¥143.60 Million | CN¥107.20 Million | ▲ +156.0% |
| 2012 | -0.45x | CN¥-68.95 Million | CN¥152.21 Million | CN¥221.17 Million | ▲ +92.9% |
| 2011 | -6.37x | CN¥-226.87 Million | CN¥35.64 Million | CN¥262.51 Million | ▼ -341.7% |
| 2010 | -1.44x | CN¥-66.65 Million | CN¥46.25 Million | CN¥112.90 Million | ▼ -328.4% |
| 2009 | 0.63x | CN¥85.24 Million | CN¥135.06 Million | CN¥49.82 Million | ▲ +66.5% |
| 2008 | 0.38x | CN¥29.46 Million | CN¥77.74 Million | CN¥48.28 Million | ▼ -58.7% |
| 2007 | 0.92x | CN¥66.14 Million | CN¥72.01 Million | CN¥5.87 Million | ▲ +159.4% |
| 2006 | -1.54x | CN¥-1.89 Million | CN¥1.22 Million | CN¥3.12 Million | — |